Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Masafumi Sata

Osimertinib, a Third‐generation EGFR Tyrosine Kinase Inhibitor: A Retrospective Multicenter Study of Its Real‐world Efficacy and Safety in Advanced/Recurrent Non‐small Cell Lung Carcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2020English

Related publications

ALK, ROS1 and EGFR Next-Generation Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer

Oncology in Clinical Practice
Oncology
2019English

Real-World Effectiveness and Safety of Nivolumab in Patients With Non-Small Cell Lung Cancer: A Multicenter Retrospective Observational Study in Japan

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Efficacy, Safety, and Resistance Profile of Osimertinib in T790M Mutation-Positive Non-Small Cell Lung Cancer in Real-World Practice

PLoS ONE
Multidisciplinary
2019English

P1.01-62 the Third Generation Irreversible EGFR Inhibitor HS-10296 in Advanced Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma

PLoS ONE
Multidisciplinary
2013English

Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations

OncoTargets and Therapy
OncologyPharmacology
2016English

Overcoming T790M Mutant Small Cell Lung Cancer With the Third-Generation EGFR-TKI Osimertinib

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2018English

P2.13-13 Real-World Study of Osimertinib in EGFR T790m-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Impact of Single Nucleotide Polymorphisms on the Efficacy and Toxicity of Egfr Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer Patients

Mutation Research - Reviews in Mutation Research
MutagenesisHealthGeneticsToxicology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy